{"id":7606,"name":"mRNA Vaccine Risk Assessment Platform","purpose":"A platform that analyzes FDA application reviews and related news sentiment, specifically regarding mRNA vaccines, identifying potential red flags and providing risk scores for vaccine developers and investors. It addresses concerns over agency hostility and aims to proactively mitigate risks.","profitable":1,"date_generated":"Wednesday February 2026 11:56","reference":"mrna-risk-assessment","technology_advise":["Python","PostgreSQL","Medium"],"development_time_estimation_mvp_in_hours":180,"grade":7.8,"category":"healthcare","view_count":68,"similar_ideas":[{"id":19586,"name":"Personalized mRNA Vaccine Advisor","grade":7.5,"category":"healthcare"},{"id":7599,"name":"Vaccine Confidence Monitor","grade":7.8,"category":"healthcare"},{"id":19623,"name":"mRNA Insights","grade":6.5,"category":"mobile"},{"id":11647,"name":"Neo-Antigen Therapy Risk Analyzer","grade":7.8,"category":"healthcare"},{"id":2189,"name":"Missile Risk Assessment Platform","grade":7.8,"category":null}],"source_headline":"FDA refuses to review Moderna's mRNA flu vaccine"}